Immunofluorescence co-localization assay confirmed that FBX8 could co-localize with HIF-1α, CDK4 and C-myc in CRC cells, and the co-localization was enhanced in the presence of MG132. This evidence concerns the gene FBXO8 and colorectal carcinoma.